Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	molecular adaptor activity	MYT1L MAK SNW1 SHANK2 BRD4 SH3KBP1 ARID5B ATF7IP2 SMARCA4 GAB3 MICAL3 ZC3H18 TRDN CREBBP EP300 KDM1A GAB1 GAB2 DNMT3A	7.85e-06	1356	90	19	GO:0060090
GeneOntologyMolecularFunction	transcription coactivator activity	MYT1L MAK SNW1 BRD4 ARID5B SMARCA4 CREBBP EP300 KDM1A	9.12e-06	303	90	9	GO:0003713
GeneOntologyMolecularFunction	nuclear androgen receptor binding	SNW1 SMARCA4 EP300 KDM1A	1.43e-05	33	90	4	GO:0050681
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MYT1L MAK SNW1 SHANK2 BRD4 ARID5B ATF7IP2 SMARCA4 GAB3 ZC3H18 TRDN CREBBP EP300 KDM1A GAB1 GAB2 DNMT3A	1.44e-05	1160	90	17	GO:0030674
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	2.01e-05	2	90	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	2.01e-05	2	90	2	GO:0044017
GeneOntologyMolecularFunction	bHLH transcription factor binding	TCF12 CREBBP EP300 KDM1A	2.27e-05	37	90	4	GO:0043425
GeneOntologyMolecularFunction	p53 binding	BRD4 SMARCA4 CREBBP EP300 KDM1A	2.54e-05	77	90	5	GO:0002039
GeneOntologyMolecularFunction	transcription coregulator activity	MYT1L MAK SNW1 BRD4 ARID5B ATF7IP2 SMARCA4 CREBBP EP300 KDM1A DNMT3A	4.43e-05	562	90	11	GO:0003712
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	6.01e-05	3	90	2	GO:0043993
GeneOntologyMolecularFunction	chromatin binding	TNRC18 BRD4 NOC3L SMARCA4 NR1H3 CREBBP BAHD1 TOP1 EP300 KDM1A CBX8 DNMT3A	1.17e-04	739	90	12	GO:0003682
GeneOntologyMolecularFunction	mRNA cap binding complex binding	ZC3H18 PHAX	1.20e-04	4	90	2	GO:0140262
GeneOntologyMolecularFunction	mRNA m(6)A methyltransferase activity	METTL16 METTL14	1.20e-04	4	90	2	GO:0001734
GeneOntologyMolecularFunction	MRF binding	CREBBP KDM1A	2.98e-04	6	90	2	GO:0043426
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD4 SMARCA4 EP300	3.63e-04	31	90	3	GO:0140033
GeneOntologyMolecularFunction	lncRNA binding	SMARCA4 KDM1A DNMT3A	5.22e-04	35	90	3	GO:0106222
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	SP100 SNW1 SMARCA4 NR1H3 CREBBP EP300 KDM1A DNMT3A	5.89e-04	417	90	8	GO:0061629
GeneOntologyMolecularFunction	SMAD binding	SNW1 TCF12 CREBBP EP300	6.18e-04	86	90	4	GO:0046332
GeneOntologyMolecularFunction	chromatin DNA binding	SMARCA4 NR1H3 CREBBP TOP1 EP300	9.55e-04	167	90	5	GO:0031490
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	SP100 SNW1 TCF12 SMARCA4 NR1H3 CREBBP EP300 KDM1A DNMT3A	1.24e-03	582	90	9	GO:0140297
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate binding	WASHC2C JPH2 GAB2	1.40e-03	49	90	3	GO:0005547
GeneOntologyMolecularFunction	mRNA methyltransferase activity	METTL16 METTL14	1.52e-03	13	90	2	GO:0008174
GeneOntologyMolecularFunction	histone acetyltransferase activity	BAZ1A CREBBP EP300	1.58e-03	51	90	3	GO:0004402
GeneOntologyMolecularFunction	nuclear receptor binding	SNW1 SMARCA4 NR1H3 EP300 KDM1A	1.58e-03	187	90	5	GO:0016922
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	BAZ1A CREBBP EP300	1.96e-03	55	90	3	GO:0061733
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	CREBBP EP300	2.03e-03	15	90	2	GO:0010484
GeneOntologyMolecularFunction	transcription factor binding	SP100 SNW1 TCF12 PCLO SMARCA4 NR1H3 CREBBP EP300 KDM1A DNMT3A	2.06e-03	753	90	10	GO:0008134
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	BAZ1A CREBBP EP300	2.52e-03	60	90	3	GO:0034212
GeneOntologyMolecularFunction	signaling adaptor activity	SHANK2 GAB3 GAB1 GAB2	2.77e-03	129	90	4	GO:0035591
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	CTR9 BRD4 CREBBP	3.30e-03	66	90	3	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	CTR9 BRD4 CREBBP	3.30e-03	66	90	3	GO:0001098
GeneOntologyMolecularFunction	transcription coregulator binding	PCLO SMARCA4 CREBBP EP300	3.71e-03	140	90	4	GO:0001221
GeneOntologyMolecularFunction	transcription corepressor activity	SNW1 SMARCA4 CREBBP KDM1A DNMT3A	3.79e-03	229	90	5	GO:0003714
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	CREBBP EP300	3.99e-03	21	90	2	GO:0042975
GeneOntologyMolecularFunction	DNA polymerase binding	SMARCA4 SMG6	4.78e-03	23	90	2	GO:0070182
GeneOntologyMolecularFunction	phosphatidylinositol-5-phosphate binding	WASHC2C JPH2	4.78e-03	23	90	2	GO:0010314
GeneOntologyMolecularFunction	N-acetyltransferase activity	BAZ1A CREBBP EP300	5.28e-03	78	90	3	GO:0008080
GeneOntologyBiologicalProcess	negative regulation of gene expression, epigenetic	BAZ1A CTR9 ATF7IP2 SMARCA4 BAHD1 KDM1A CBX8 DNMT3A	2.51e-06	203	88	8	GO:0045814
GeneOntologyBiologicalProcess	viral transcription	SP100 SNW1 BRD4 SMARCA4 EP300	4.83e-06	58	88	5	GO:0019083
GeneOntologyBiologicalProcess	heterochromatin formation	BAZ1A ATF7IP2 SMARCA4 BAHD1 KDM1A CBX8 DNMT3A	6.28e-06	163	88	7	GO:0031507
GeneOntologyBiologicalProcess	epigenetic regulation of gene expression	BAZ1A CTR9 ATF7IP2 SMARCA4 BAHD1 EP300 KDM1A CBX8 DNMT3A	1.16e-05	330	88	9	GO:0040029
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	MYT1L SP100 SNW1 CTR9 ARID5B SMARCA4 JPH2 MAGEC3 NR1H3 SMO CREBBP EP300 KDM1A CBX8 DNMT3A	3.61e-05	1053	88	15	GO:0000122
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	ATF7IP2 SMARCA4 KDM1A DNMT3A	3.69e-05	44	88	4	GO:0006346
GeneOntologyBiologicalProcess	positive regulation by host of viral transcription	SNW1 SMARCA4 EP300	4.89e-05	17	88	3	GO:0043923
GeneOntologyBiologicalProcess	chromatin remodeling	BAZ1A CTR9 BRD4 ATF7IP2 SMARCA4 CREBBP BAHD1 TOP1 EP300 KDM1A CBX8 DNMT3A	7.11e-05	741	88	12	GO:0006338
GeneOntologyBiologicalProcess	facultative heterochromatin formation	ATF7IP2 SMARCA4 KDM1A DNMT3A	8.93e-05	55	88	4	GO:0140718
GeneOntologyBiologicalProcess	positive regulation of neuron projection development	NF1 PLA2G3 CAPRIN2 COBL PLXNB2 EP300 KDM1A	9.49e-05	249	88	7	GO:0010976
GeneOntologyBiologicalProcess	viral gene expression	SP100 SNW1 BRD4 SMARCA4 EP300	1.04e-04	109	88	5	GO:0019080
GeneOntologyBiologicalProcess	N-terminal peptidyl-lysine acetylation	CREBBP EP300	1.07e-04	4	88	2	GO:0018076
GeneOntologyBiologicalProcess	stimulatory C-type lectin receptor signaling pathway	PAK2 CREBBP EP300	1.25e-04	23	88	3	GO:0002223
GeneOntologyBiologicalProcess	cellular response to lectin	PAK2 CREBBP EP300	1.25e-04	23	88	3	GO:1990858
GeneOntologyBiologicalProcess	response to lectin	PAK2 CREBBP EP300	1.25e-04	23	88	3	GO:1990840
GeneOntologyBiologicalProcess	regulation of DNA binding	SP100 BRD4 SMARCA4 SMO KDM1A	1.34e-04	115	88	5	GO:0051101
GeneOntologyBiologicalProcess	regulation of heterochromatin formation	BAZ1A ATF7IP2 KDM1A	1.42e-04	24	88	3	GO:0031445
GeneOntologyBiologicalProcess	positive regulation of cellular response to hypoxia	EP300 DNMT3A	1.78e-04	5	88	2	GO:1900039
GeneOntologyBiologicalProcess	peptidyl-lysine acetylation	SMO CREBBP EP300	2.28e-04	28	88	3	GO:0018394
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	MYT1L SP100 SNW1 CTR9 ARID5B SMARCA4 JPH2 MAGEC3 NR1H3 SMO CREBBP BAHD1 EP300 KDM1A CBX8 DNMT3A	2.55e-04	1399	88	16	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	MYT1L SP100 SNW1 CTR9 ARID5B SMARCA4 JPH2 MAGEC3 NR1H3 SMO CREBBP BAHD1 EP300 KDM1A CBX8 DNMT3A	2.85e-04	1413	88	16	GO:1902679
GeneOntologyBiologicalProcess	regulation of androgen receptor signaling pathway	SMARCA4 EP300 KDM1A	3.09e-04	31	88	3	GO:0060765
GeneOntologyBiologicalProcess	blastocyst growth	CTR9 BRD4 SMARCA4	3.73e-04	33	88	3	GO:0001832
GeneOntologyBiologicalProcess	chromatin organization	BAZ1A CTR9 BRD4 ATF7IP2 SMARCA4 CREBBP BAHD1 TOP1 EP300 KDM1A CBX8 DNMT3A	4.13e-04	896	88	12	GO:0006325
GeneOntologyBiologicalProcess	positive regulation of cellular response to transforming growth factor beta stimulus	SNW1 CREBBP EP300	4.45e-04	35	88	3	GO:1903846
GeneOntologyBiologicalProcess	positive regulation of transforming growth factor beta receptor signaling pathway	SNW1 CREBBP EP300	4.45e-04	35	88	3	GO:0030511
GeneOntologyBiologicalProcess	primitive erythrocyte differentiation	SMARCA4 KDM1A	4.96e-04	8	88	2	GO:0060319
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell lineage commitment	BRD4 EP300	4.96e-04	8	88	2	GO:2000330
GeneOntologyCellularComponent	nuclear body	ATXN2L SRRM1 SP100 SNW1 TCF12 AFF2 RAPH1 CTR9 NOC3L SNRNP40 PTPN23 XRRA1 ZC3H18 INAVA PHAX CREBBP	1.38e-06	903	90	16	GO:0016604
GeneOntologyCellularComponent	transcription elongation factor complex	SNW1 AFF2 CTR9 BRD4	9.94e-05	56	90	4	GO:0008023
GeneOntologyCellularComponent	nuclear speck	ATXN2L SRRM1 SNW1 TCF12 AFF2 CTR9 NOC3L SNRNP40 ZC3H18	1.00e-04	431	90	9	GO:0016607
GeneOntologyCellularComponent	chromosomal region	SP100 BAZ1A SMARCA4 MTCL1 CREBBP KDM1A DNMT3A SMG6	4.65e-04	421	90	8	GO:0098687
GeneOntologyCellularComponent	cyclin/CDK positive transcription elongation factor complex	SNW1 BRD4	6.47e-04	9	90	2	GO:0008024
GeneOntologyCellularComponent	junctional membrane complex	JPH2 TRDN	6.47e-04	9	90	2	GO:0030314
GeneOntologyCellularComponent	nuclear protein-containing complex	SRRM1 SP100 SNW1 TCF12 AFF2 BAZ1A CTR9 BRD4 SNRNP40 SMARCA4 NR1H3 CREBBP BAHD1 CBX8 SMG6	7.52e-04	1377	90	15	GO:0140513
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	JPH2 TRDN	8.07e-04	10	90	2	GO:0014701
GeneOntologyCellularComponent	nuclear periphery	SRRM1 SP100 SNW1 SMARCA4 DNMT3A	8.67e-04	171	90	5	GO:0034399
GeneOntologyCellularComponent	heterochromatin	BAZ1A SMARCA4 CBX8 DNMT3A	9.54e-04	101	90	4	GO:0000792
GeneOntologyCellularComponent	dendritic growth cone	COBL SMO	1.18e-03	12	90	2	GO:0044294
HumanPheno	Meningioma	NF1 SMO CREBBP EP300 KDM1A	3.88e-06	44	29	5	HP:0002858
HumanPheno	Deviated nasal septum	NF1 CREBBP EP300	5.72e-06	7	29	3	HP:0004411
HumanPheno	Neoplasm of the nervous system	NF1 BRD4 SMO CREBBP EP300 KDM1A LUZP1 DNMT3A	8.58e-06	195	29	8	HP:0004375
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	3.13e-05	2	29	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	3.13e-05	2	29	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	3.13e-05	2	29	2	HP:0001042
HumanPheno	Neoplasm of the central nervous system	NF1 BRD4 SMO CREBBP EP300 KDM1A LUZP1	4.60e-05	178	29	7	HP:0100006
HumanPheno	Obesity	MYT1L MAK BRD4 SH3KBP1 SMO CREBBP EP300 KDM1A LUZP1 DNMT3A	6.91e-05	425	29	10	HP:0001513
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	9.36e-05	3	29	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	9.36e-05	3	29	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	9.36e-05	3	29	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	9.36e-05	3	29	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	9.36e-05	3	29	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	9.36e-05	3	29	2	HP:0005895
HumanPheno	Elbow dislocation	GDF5 SCARF2 BRD4 CREBBP EP300	9.41e-05	84	29	5	HP:0003042
HumanPheno	Deviation of the hallux	GDF5 TCF12 SCARF2 CREBBP EP300	1.18e-04	88	29	5	HP:0010051
HumanPheno	Chiari type I malformation	SMO CREBBP EP300 DNMT3A	1.39e-04	48	29	4	HP:0007099
HumanPheno	Abnormal hallux morphology	GDF5 TCF12 SCARF2 SMO TNNT3 CREBBP EP300	1.40e-04	212	29	7	HP:0001844
HumanPheno	Conductive hearing impairment	GDF5 MAK NF1 BRD4 COBLL1 CREBBP EP300 LUZP1 DNMT3A	1.47e-04	373	29	9	HP:0000405
HumanPheno	Abnormal nasal bridge morphology	MYT1L GDF5 NF1 AFF2 SCARF2 BRD4 PCLO SMARCA4 PAK2 SMO TNNT3 CREBBP EP300 KDM1A LUZP1	1.52e-04	1029	29	15	HP:0000422
HumanPheno	Abnormality of the frontal hairline	TCF12 BRD4 SMARCA4 SMO CREBBP EP300 KDM1A	1.53e-04	215	29	7	HP:0000599
HumanPheno	Hirsutism	BRD4 SMARCA4 SMO CREBBP EP300 KDM1A LUZP1	1.57e-04	216	29	7	HP:0001007
HumanPheno	Abnormality of the hairline	TCF12 NF1 BRD4 SMARCA4 SMO CREBBP EP300 KDM1A	1.65e-04	294	29	8	HP:0009553
HumanPheno	Upper extremity joint dislocation	GDF5 SCARF2 BRD4 CREBBP EP300	1.78e-04	96	29	5	HP:0030310
HumanPheno	Trichiasis	CREBBP EP300	1.86e-04	4	29	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	1.86e-04	4	29	2	HP:0410266
HumanPheno	Talon cusp	CREBBP EP300	1.86e-04	4	29	2	HP:0011087
HumanPheno	Widened distal phalanges	CREBBP EP300	1.86e-04	4	29	2	HP:0006200
HumanPheno	Vascular ring	CREBBP EP300	1.86e-04	4	29	2	HP:0010775
HumanPheno	Hepatic hemangioma	CREBBP EP300	1.86e-04	4	29	2	HP:0031207
HumanPheno	Abnormal proximal phalanx morphology of the hand	GDF5 BRD4 CREBBP EP300	1.90e-04	52	29	4	HP:0009834
HumanPheno	Functional abnormality of the middle ear	GDF5 MAK NF1 BRD4 COBLL1 CREBBP EP300 LUZP1 DNMT3A	1.92e-04	386	29	9	HP:0011452
HumanPheno	Narrow nasal bridge	GDF5 SMARCA4 CREBBP EP300	2.05e-04	53	29	4	HP:0000446
HumanPheno	Increased body weight	MYT1L MAK BRD4 SH3KBP1 SMO CREBBP EP300 KDM1A LUZP1 DNMT3A	2.33e-04	491	29	10	HP:0004324
HumanPheno	Panic attack	NF1 CREBBP EP300 DNMT3A	2.36e-04	55	29	4	HP:0025269
HumanPheno	Non-epileptic seizure	NF1 CREBBP EP300 DNMT3A	2.54e-04	56	29	4	HP:0033052
HumanPheno	Benign neoplasm of the central nervous system	NF1 SMO CREBBP EP300 KDM1A	2.71e-04	105	29	5	HP:0100835
HumanPheno	Abnormality of the incisor	BRD4 COBLL1 CREBBP EP300 DNMT3A	3.09e-04	108	29	5	HP:0000676
HumanPheno	Papillary cystadenoma of the epididymis	CREBBP EP300	3.10e-04	5	29	2	HP:0009715
HumanPheno	Supernumerary cusp	CREBBP EP300	3.10e-04	5	29	2	HP:0033777
HumanPheno	Epididymal neoplasm	CREBBP EP300	3.10e-04	5	29	2	HP:0030421
HumanPheno	Everted upper lip vermilion	SMARCA4 CREBBP DNMT3A	3.10e-04	24	29	3	HP:0010803
HumanPheno	Abnormal patella morphology	GDF5 SCARF2 CREBBP EP300 DNMT3A	3.23e-04	109	29	5	HP:0003045
HumanPheno	Congenital abnormal hair pattern	TCF12 NF1 BRD4 SMARCA4 SMO CREBBP EP300 KDM1A	3.45e-04	327	29	8	HP:0011361
HumanPheno	Abnormal incisor morphology	BRD4 COBLL1 CREBBP EP300	3.76e-04	62	29	4	HP:0011063
HumanPheno	Abnormality of the humeroradial joint	GDF5 SCARF2 CREBBP EP300	3.76e-04	62	29	4	HP:0100744
HumanPheno	Diagnostic behavioral phenotype	MYT1L TCF12 NF1 AFF2 BRD4 SMARCA4 PAK2 CREBBP NDUFS1 EP300 LUZP1 DNMT3A	4.24e-04	747	29	12	HP:0025783
HumanPheno	Large foramen magnum	CREBBP EP300	4.63e-04	6	29	2	HP:0002700
HumanPheno	Deviation of toes	GDF5 TCF12 SCARF2 CREBBP EP300	4.66e-04	118	29	5	HP:0100498
HumanPheno	Short columella	CREBBP EP300 DNMT3A	5.49e-04	29	29	3	HP:0002000
HumanPheno	Neoplasm of the peripheral nervous system	NF1 SMO KDM1A DNMT3A	5.99e-04	70	29	4	HP:0100007
HumanPheno	Preaxial foot polydactyly	SMO CREBBP EP300	6.08e-04	30	29	3	HP:0001841
HumanPheno	Patellar dislocation	GDF5 SCARF2 CREBBP EP300	6.33e-04	71	29	4	HP:0002999
HumanPheno	Unicoronal synostosis	TCF12 SMO	6.46e-04	7	29	2	HP:0011315
HumanPheno	Short thumb	GDF5 BRD4 CREBBP EP300 KDM1A	6.54e-04	127	29	5	HP:0009778
HumanPheno	Joint hypermobility	GDF5 TCF12 NF1 SCARF2 SMARCA4 PAK2 CREBBP EP300 KDM1A DNMT3A	6.54e-04	557	29	10	HP:0001382
HumanPheno	Brachydactyly	GDF5 TCF12 BRD4 SMARCA4 SMO TNNT3 CREBBP EP300 KDM1A LUZP1 DNMT3A	6.85e-04	670	29	11	HP:0001156
HumanPheno	Blepharophimosis	SCARF2 SMO CREBBP EP300 DNMT3A	7.02e-04	129	29	5	HP:0000581
HumanPheno	Short digit	GDF5 TCF12 BRD4 SMARCA4 SMO TNNT3 CREBBP EP300 KDM1A LUZP1 DNMT3A	7.03e-04	672	29	11	HP:0011927
HumanPheno	Abnormal toe phalanx morphology	GDF5 SMARCA4 SMO CREBBP EP300	7.27e-04	130	29	5	HP:0010161
HumanPheno	Autistic behavior	MYT1L TCF12 NF1 AFF2 BRD4 SMARCA4 PAK2 CREBBP NDUFS1 EP300 LUZP1	7.59e-04	678	29	11	HP:0000729
HumanPheno	Syringomyelia	CREBBP EP300 KDM1A	8.07e-04	33	29	3	HP:0003396
HumanPheno	Frontal upsweep of hair	BRD4 CREBBP EP300	8.07e-04	33	29	3	HP:0002236
HumanPheno	Broad hallux	GDF5 TNNT3 CREBBP EP300	8.19e-04	76	29	4	HP:0010055
HumanPheno	Abnormal number of permanent teeth	COBLL1 CREBBP EP300	9.61e-04	35	29	3	HP:0011044
HumanPheno	Neoplasm by histology	GDF5 NF1 BRD4 SMARCA4 PAK2 SMO EP300 LUZP1	9.98e-04	383	29	8	HP:0011792
HumanPheno	Aplasia/Hypoplasia of toe	GDF5 SMARCA4 TNNT3 EP300 DNMT3A	1.02e-03	140	29	5	HP:0001991
HumanPheno	Abnormal upper limb bone morphology	GDF5 TCF12 SCARF2 BRD4 SMO TNNT3 CREBBP EP300 DNMT3A	1.03e-03	484	29	9	HP:0040070
HumanPheno	Abnormality of the distal phalanx of the thumb	GDF5 CREBBP EP300	1.04e-03	36	29	3	HP:0009617
HumanPheno	Aplasia/Hypoplasia of the phalanges of the toes	GDF5 SMARCA4 EP300	1.04e-03	36	29	3	HP:0010173
HumanPheno	Abnormal hand morphology	GDF5 TCF12 NF1 AFF2 SCARF2 BRD4 SMARCA4 SMO TNNT3 CREBBP EP300 KDM1A LUZP1 DNMT3A	1.07e-03	1082	29	14	HP:0005922
HumanPheno	Pilomatrixoma	CREBBP EP300	1.10e-03	9	29	2	HP:0030434
HumanPheno	Cervical cord compression	CREBBP EP300	1.10e-03	9	29	2	HP:0002341
HumanPheno	Single transverse palmar crease	GDF5 TCF12 BRD4 TNNT3 CREBBP EP300	1.11e-03	215	29	6	HP:0000954
HumanPheno	Aplasia/Hypoplasia involving bones of the feet	GDF5 BRD4 SMARCA4 TNNT3 EP300 LUZP1 DNMT3A	1.12e-03	298	29	7	HP:0006494
HumanPheno	Abnormal morphology of the radius	GDF5 SCARF2 BRD4 TNNT3 CREBBP EP300	1.16e-03	217	29	6	HP:0002818
HumanPheno	Neuroendocrine neoplasm	NF1 KDM1A DNMT3A	1.22e-03	38	29	3	HP:0100634
HumanPheno	Low anterior hairline	TCF12 BRD4 SMARCA4 CREBBP EP300	1.27e-03	147	29	5	HP:0000294
HumanPheno	Broad phalanx	GDF5 SMO CREBBP EP300 DNMT3A	1.31e-03	148	29	5	HP:0006009
HumanPheno	Broad phalanges of the hand	GDF5 SMO CREBBP EP300 DNMT3A	1.31e-03	148	29	5	HP:0009768
HumanPheno	Poor coordination	AFF2 CREBBP EP300	1.32e-03	39	29	3	HP:0002370
HumanPheno	Broad toe	GDF5 TNNT3 CREBBP EP300	1.36e-03	87	29	4	HP:0001837
HumanPheno	Frontal hirsutism	CREBBP EP300	1.37e-03	10	29	2	HP:0011335
HumanPheno	Depressed nasal bridge	NF1 SCARF2 BRD4 PCLO SMARCA4 PAK2 SMO CREBBP EP300 LUZP1	1.38e-03	612	29	10	HP:0005280
HumanPheno	Flattened nasal bridge	NF1 SCARF2 BRD4 PCLO SMARCA4 PAK2 SMO CREBBP EP300 LUZP1	1.38e-03	612	29	10	HP:0000425
HumanPheno	Aplasia/Hypoplasia of the thumb	GDF5 BRD4 CREBBP EP300 KDM1A	1.39e-03	150	29	5	HP:0009601
HumanPheno	Abnormal upper lip morphology	MYT1L NF1 AFF2 BRD4 COBLL1 PCLO SMARCA4 SMO CREBBP EP300 KDM1A LUZP1 DNMT3A	1.44e-03	980	29	13	HP:0000177
HumanPheno	Abnormal 5th finger morphology	GDF5 AFF2 BRD4 SMARCA4 SMO CREBBP EP300 KDM1A LUZP1	1.49e-03	509	29	9	HP:0004207
HumanPheno	Broad thumb	GDF5 SMO CREBBP EP300	1.54e-03	90	29	4	HP:0011304
HumanPheno	Broad finger	GDF5 SMO CREBBP EP300 DNMT3A	1.56e-03	154	29	5	HP:0001500
HumanPheno	Thick eyebrow	BRD4 SMARCA4 CREBBP EP300 DNMT3A	1.56e-03	154	29	5	HP:0000574
HumanPheno	Neoplasm of the endocrine system	NF1 SMARCA4 SMO KDM1A DNMT3A	1.61e-03	155	29	5	HP:0100568
HumanPheno	Lower extremity joint dislocation	GDF5 SCARF2 BRD4 SMO TNNT3 CREBBP EP300	1.63e-03	318	29	7	HP:0030311
HumanPheno	Abnormal hair whorl	BRD4 CREBBP EP300	1.64e-03	42	29	3	HP:0010721
HumanPheno	Abnormal subclavian artery morphology	CREBBP EP300	1.67e-03	11	29	2	HP:0031251
HumanPheno	Neuroepithelial neoplasm	NF1 BRD4 SMO LUZP1	1.67e-03	92	29	4	HP:0030063
HumanPheno	Thin corpus callosum	MYT1L TCF12 NF1 BRD4 PCLO SMARCA4 PTPN23 SMO CREBBP EP300 KDM1A LUZP1	1.69e-03	868	29	12	HP:0033725
HumanPheno	Broad long bones	GDF5 SMO CREBBP EP300 DNMT3A	1.70e-03	157	29	5	HP:0005622
HumanPheno	Tooth malposition	TCF12 SCARF2 BRD4 COBLL1 CREBBP EP300 KDM1A DNMT3A	1.77e-03	418	29	8	HP:0000692
HumanPheno	Abnormal forearm bone morphology	GDF5 SCARF2 BRD4 TNNT3 CREBBP EP300	1.79e-03	236	29	6	HP:0040072
MousePheno	abnormal mast cell differentiation	TPSAB1 PLA2G3 GAB2	1.35e-05	10	69	3	MP:0005462
MousePheno	short premaxilla	BRD4 ARID5B CREBBP	3.18e-05	13	69	3	MP:0000091
MousePheno	biflagellated sperm	BAZ1A PLA2G3	7.18e-05	3	69	2	MP:0031410
Domain	Bromodomain_CS	BAZ1A BRD4 SMARCA4 CREBBP EP300	1.19e-07	26	87	5	IPR018359
Domain	BROMODOMAIN_1	BAZ1A BRD4 SMARCA4 CREBBP EP300	7.57e-07	37	87	5	PS00633
Domain	Bromodomain	BAZ1A BRD4 SMARCA4 CREBBP EP300	8.68e-07	38	87	5	PF00439
Domain	BROMODOMAIN_2	BAZ1A BRD4 SMARCA4 CREBBP EP300	1.28e-06	41	87	5	PS50014
Domain	BROMO	BAZ1A BRD4 SMARCA4 CREBBP EP300	1.45e-06	42	87	5	SM00297
Domain	Bromodomain	BAZ1A BRD4 SMARCA4 CREBBP EP300	1.45e-06	42	87	5	IPR001487
Domain	-	BAZ1A BRD4 SMARCA4 CREBBP EP300	1.45e-06	42	87	5	1.20.920.10
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	2.14e-05	2	87	2	IPR014744
Domain	HAT_KAT11	CREBBP EP300	2.14e-05	2	87	2	PF08214
Domain	KIX	CREBBP EP300	2.14e-05	2	87	2	PS50952
Domain	ZnF_TAZ	CREBBP EP300	2.14e-05	2	87	2	SM00551
Domain	CBP_P300_HAT	CREBBP EP300	2.14e-05	2	87	2	IPR031162
Domain	DUF902	CREBBP EP300	2.14e-05	2	87	2	PF06001
Domain	Cordon-bleu_ubiquitin_domain	COBLL1 COBL	2.14e-05	2	87	2	IPR019025
Domain	-	CREBBP EP300	2.14e-05	2	87	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	2.14e-05	2	87	2	IPR010303
Domain	-	CREBBP EP300	2.14e-05	2	87	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	2.14e-05	2	87	2	PF09030
Domain	Cobl	COBLL1 COBL	2.14e-05	2	87	2	PF09469
Domain	-	CREBBP EP300	2.14e-05	2	87	2	1.10.246.20
Domain	zf-TAZ	CREBBP EP300	2.14e-05	2	87	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	2.14e-05	2	87	2	PS50134
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	2.14e-05	2	87	2	IPR013178
Domain	KAT11	CREBBP EP300	2.14e-05	2	87	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	2.14e-05	2	87	2	IPR000197
Domain	KIX_dom	CREBBP EP300	2.14e-05	2	87	2	IPR003101
Domain	KIX	CREBBP EP300	2.14e-05	2	87	2	PF02172
Domain	CBP_P300_HAT	CREBBP EP300	2.14e-05	2	87	2	PS51727
Domain	Nuc_rcpt_coact	CREBBP EP300	3.18e-04	6	87	2	IPR009110
Domain	DUF3585	EHBP1 MICAL3	4.44e-04	7	87	2	IPR022735
Domain	DUF3585	EHBP1 MICAL3	4.44e-04	7	87	2	PF12130
Domain	BAH	TNRC18 BAHD1	1.15e-03	11	87	2	SM00439
Domain	BAH	TNRC18 BAHD1	1.15e-03	11	87	2	PF01426
Domain	BAH	TNRC18 BAHD1	1.15e-03	11	87	2	PS51038
Domain	BAH_dom	TNRC18 BAHD1	1.15e-03	11	87	2	IPR001025
Domain	-	ANTXRL PAK2	1.37e-03	12	87	2	3.90.810.10
Domain	FERM-adjacent	PTPN4 EPB41L4B	1.62e-03	13	87	2	IPR014847
Domain	FA	PTPN4 EPB41L4B	1.62e-03	13	87	2	SM01195
Domain	FA	PTPN4 EPB41L4B	1.62e-03	13	87	2	PF08736
Domain	-	PTPN4 RAPH1 EPB41L4B GAB3 PLEKHA6 GAB1 GAB2	2.32e-03	391	87	7	2.30.29.30
Domain	WH2	COBLL1 COBL	2.47e-03	16	87	2	PF02205
Domain	ZZ	CREBBP EP300	3.13e-03	18	87	2	PF00569
Domain	RasGAP_dom	NF1 PLXNB2	3.13e-03	18	87	2	IPR001936
Domain	ZF_ZZ_2	CREBBP EP300	3.13e-03	18	87	2	PS50135
Domain	ZF_ZZ_1	CREBBP EP300	3.13e-03	18	87	2	PS01357
Domain	Znf_ZZ	CREBBP EP300	3.48e-03	19	87	2	IPR000433
Domain	ZnF_ZZ	CREBBP EP300	3.48e-03	19	87	2	SM00291
Domain	PH_dom-like	PTPN4 RAPH1 EPB41L4B GAB3 PLEKHA6 GAB1 GAB2	3.73e-03	426	87	7	IPR011993
Domain	Ez/rad/moesin-like	PTPN4 EPB41L4B	4.25e-03	21	87	2	IPR000798
Domain	WH2_dom	COBLL1 COBL	4.25e-03	21	87	2	IPR003124
Domain	CRIB_dom	ANTXRL PAK2	4.25e-03	21	87	2	IPR000095
Domain	PH	RAPH1 GAB3 PLEKHA6 GAB1 GAB2	4.34e-03	229	87	5	PF00169
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	SMARCA4 CREBBP EP300 DNMT3A	1.27e-06	21	56	4	M39593
Pathway	BIOCARTA_VDR_PATHWAY	SNW1 SMARCA4 CREBBP EP300	1.55e-06	22	56	4	MM1370
Pathway	REACTOME_SUMOYLATION	SP100 NR1H3 CREBBP TOP1 EP300 CBX8 DNMT3A	9.28e-06	189	56	7	M27214
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	SNW1 CREBBP EP300	2.10e-05	14	56	3	M27808
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	CTR9 SMARCA4 SMO CREBBP EP300 KDM1A GAB1 DNMT3A	2.30e-05	301	56	8	MM15983
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	SNW1 CREBBP EP300	3.21e-05	16	56	3	M27121
Pathway	BIOCARTA_PML_PATHWAY	PRAM1 SP100 CREBBP	3.88e-05	17	56	3	M4891
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	SNW1 CREBBP EP300	6.45e-05	20	56	3	M27881
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PAK2 CREBBP EP300	7.51e-05	21	56	3	M27485
Pathway	BIOCARTA_VDR_PATHWAY	SMARCA4 CREBBP EP300	1.13e-04	24	56	3	M13404
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	SNW1 CREBBP EP300	1.28e-04	25	56	3	M27880
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.54e-04	5	56	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	1.54e-04	5	56	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	1.54e-04	5	56	2	M48023
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	1.54e-04	5	56	2	M27228
Pathway	KEGG_RENAL_CELL_CARCINOMA	PAK2 CREBBP EP300 GAB1	1.69e-04	70	56	4	M13266
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	2.30e-04	6	56	2	M22062
Pathway	PID_MET_PATHWAY	SH3KBP1 PAK2 GAB1 GAB2	2.69e-04	79	56	4	M48
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	3.21e-04	7	56	2	MM1573
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	SMARCA4 EP300 CBX8	3.26e-04	34	56	3	MM15531
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	SMARCA4 EP300 CBX8	4.19e-04	37	56	3	M27797
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	NR1H3 EP300 KDM1A	4.19e-04	37	56	3	M29790
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	4.27e-04	8	56	2	M22058
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	4.27e-04	8	56	2	M48022
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	CREBBP EP300	4.27e-04	8	56	2	M48024
Pathway	REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES	CREBBP EP300	4.27e-04	8	56	2	M46443
Pathway	REACTOME_SUMOYLATION	SP100 NR1H3 TOP1 EP300 CBX8	5.44e-04	169	56	5	MM14919
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	CREBBP EP300	5.48e-04	9	56	2	M47451
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	SNW1 CREBBP EP300	6.11e-04	42	56	3	M17541
Pathway	WP_IL6_SIGNALING_PATHWAY	CREBBP EP300 GAB1 GAB2	6.60e-04	100	56	4	MM15826
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	NF1 SMARCA4	6.83e-04	10	56	2	MM1532
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS	GAB1 GAB2	6.83e-04	10	56	2	M47930
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	CREBBP EP300	6.83e-04	10	56	2	M27945
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	CREBBP EP300 CBX8	7.01e-04	44	56	3	M27295
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	ARID5B SMARCA4 CREBBP EP300 KDM1A DNMT3A	7.06e-04	272	56	6	M29619
Pathway	WP_RAS_SIGNALING	NF1 PLA2G3 PAK2 GAB1 GAB2	8.00e-04	184	56	5	M39764
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	8.33e-04	11	56	2	MM1521
Pathway	REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES	CREBBP EP300	8.33e-04	11	56	2	M48021
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	CREBBP EP300	8.33e-04	11	56	2	M26924
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	NR1H3 EP300 KDM1A	8.51e-04	47	56	3	M29777
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	SNW1 CREBBP EP300	8.51e-04	47	56	3	M7946
Pathway	PID_HES_HEY_PATHWAY	CREBBP EP300 KDM1A	9.05e-04	48	56	3	M288
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	SNW1 CREBBP EP300	9.05e-04	48	56	3	M611
Pathway	REACTOME_SIGNALING_BY_NOTCH3	SNW1 CREBBP EP300	9.61e-04	49	56	3	M618
Pathway	BIOCARTA_CARM1_PATHWAY	CREBBP EP300	9.97e-04	12	56	2	M7968
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	CREBBP EP300	9.97e-04	12	56	2	M27765
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	NF1 SMARCA4	9.97e-04	12	56	2	M22006
Pathway	BIOCARTA_PPARA_PATHWAY	NR1H3 CREBBP EP300	1.14e-03	52	56	3	M2404
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	NR1H3 EP300	1.18e-03	13	56	2	MM15622
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	ACSL1 NR1H3 CREBBP EP300	1.22e-03	118	56	4	M27316
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	SNW1 CREBBP EP300	1.57e-03	58	56	3	M29616
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.57e-03	15	56	2	MM1339
Pathway	BIOCARTA_RELA_PATHWAY	CREBBP EP300	1.57e-03	15	56	2	M10183
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.57e-03	15	56	2	MM1439
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	CREBBP EP300	1.57e-03	15	56	2	M953
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.79e-03	16	56	2	M1296
Pathway	BIOCARTA_IL7_PATHWAY	CREBBP EP300	1.79e-03	16	56	2	MM1420
Pathway	REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS	CBX8 DNMT3A	1.79e-03	16	56	2	M27403
Pathway	BIOCARTA_PITX2_PATHWAY	CREBBP EP300	1.79e-03	16	56	2	M8516
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	CREBBP EP300	1.79e-03	16	56	2	M27940
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	2.03e-03	17	56	2	MM1509
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	CREBBP EP300	2.03e-03	17	56	2	M48025
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PAK2 EP300	2.03e-03	17	56	2	MM15215
Pathway	PID_RB_1PATHWAY	SMARCA4 CREBBP EP300	2.18e-03	65	56	3	M279
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ARID5B CREBBP EP300	2.18e-03	65	56	3	M39682
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	CREBBP EP300	2.28e-03	18	56	2	M26942
Pathway	BIOCARTA_PML_PATHWAY	SP100 CREBBP	2.28e-03	18	56	2	MM1474
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	TCF12 SMARCA4 CREBBP EP300 CBX8	2.45e-03	237	56	5	M27786
Pathway	BIOCARTA_TGFB_PATHWAY	CREBBP EP300	2.54e-03	19	56	2	M18933
Pathway	REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES	CREBBP EP300	2.54e-03	19	56	2	M46442
Pathway	REACTOME_FORMATION_OF_PARAXIAL_MESODERM	SNW1 CREBBP EP300	2.58e-03	69	56	3	M46439
Pathway	REACTOME_INTERLEUKIN_37_SIGNALING	PTPN4 PTPN23	3.10e-03	21	56	2	M27873
Pathway	REACTOME_SIGNALING_BY_NOTCH1	SNW1 CREBBP EP300	3.15e-03	74	56	3	M616
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	TCF12 SMARCA4 EP300 CBX8	3.16e-03	153	56	4	MM15522
Pathway	WP_HEDGEHOG_SIGNALING_PATHWAY	SMO CREBBP	3.40e-03	22	56	2	MM15924
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	3.40e-03	22	56	2	MM1443
Pathway	BIOCARTA_NTHI_PATHWAY	CREBBP EP300	3.72e-03	23	56	2	M2821
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L KIF23 SNW1 RAPH1 BRD4 SMARCA4 PAK2 PTPN23 PHAX CREBBP EP300 ZMYM4 KDM1A LUZP1	1.78e-10	549	91	14	38280479
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 KIF23 NF1 RAPH1 EPB41L4B BAZ1A ZC3H18 MTCL1 ZFC3H1 C1orf94 TOP1 ZMYM4	1.97e-10	361	91	12	26167880
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SRRM1 KIF23 SNW1 BAZ1A CTR9 BRD4 SNRNP40 SMARCA4 PAK2 ZC3H18 METTL16 PHAX CREBBP TOP1 EP300 KDM1A METTL14	1.06e-09	1014	91	17	32416067
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	SP100 BAZ1A BRD4 SMARCA4 CREBBP EP300 KDM1A	1.14e-09	75	91	7	25593309
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ACSL1 ATXN2L SRRM1 KIF23 SLC4A7 SNW1 NF1 ZSWIM3 CTR9 BRD4 UTP14A ARID5B PAK2 ZC3H18 METTL16 BAHD1 NDUFS1 EP300 ZMYM4	1.32e-09	1327	91	19	32694731
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EHBP1 ATXN2L SLC4A7 SHANK2 RAPH1 EPB41L4B COBLL1 SH3KBP1 PAK2 INAVA PLEKHA6 GAB1 LUZP1	2.89e-09	565	91	13	25468996
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	ATXN2L SRRM1 KIF23 SNW1 WASHC2C BAZ1A NOC3L SNRNP40 SMARCA4 COBL ZC3H18 ZFC3H1 TOP1 ZMYM4 LUZP1	5.47e-09	847	91	15	35850772
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	SRRM1 SNW1 BRD4 SMARCA4 ZC3H18 TOP1 ZMYM4	1.07e-08	103	91	7	32744500
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ACSL1 ATXN2L PRAM1 TNRC18 SNW1 TCF12 CTR9 BRD4 SNRNP40 SMARCA4 PAK2 CREBBP TOP1 EP300 ZMYM4 KDM1A	2.63e-08	1103	91	16	34189442
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L SRRM1 PRAM1 KIF23 SNW1 BAZ1A BRD4 UTP14A NOC3L SMARCA4 ZC3H18 TOP1 ZMYM4 CBX8 LUZP1	2.64e-08	954	91	15	36373674
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SRRM1 SP100 TNRC18 SHANK2 ZNF474 RAPH1 BAZ1A NHSL2 CTR9 PCLO CAPRIN2 UTP14A NOC3L ZFC3H1 TRDN TOP1 NDUFS1 LUZP1	3.14e-08	1442	91	18	35575683
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 ATXN2L SRRM1 KIF23 SLC4A7 NF1 RAPH1 BRD4 COBLL1 COBL MTCL1 GAB1 LUZP1 GAB2	5.35e-08	861	91	14	36931259
Pubmed	A human MAP kinase interactome.	EHBP1 SP100 COBLL1 PAK2 COBL PTPN23 PLEKHA6 CREBBP EP300 GAB1 GAB2	6.14e-08	486	91	11	20936779
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SRRM1 KIF23 BAZ1A BRD4 SMARCA4 ZC3H18 PHAX TOP1 ZMYM4 KDM1A CBX8 DNMT3A	6.57e-08	608	91	12	36089195
Pubmed	Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.	BRD4 SMARCA4 EP300	6.92e-08	4	91	3	30428346
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L SRRM1 KIF23 NF1 WASHC2C RAPH1 CTR9 BRD4 SMARCA4 CBLC MICAL3 ZC3H18 ZMYM4	1.16e-07	774	91	13	15302935
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	MYT1L NF1 SMARCA4 EP300	1.30e-07	18	91	4	33323119
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	KIF23 SNW1 CTR9 BRD4 SMARCA4 ZFC3H1 CREBBP ZMYM4	1.31e-07	222	91	8	37071664
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ATXN2L SRRM1 KIF23 SNW1 NF1 UTP14A NOC3L SMARCA4 ZC3H18 TOP1 NDUFS1 KDM1A	1.42e-07	653	91	12	22586326
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 ATXN2L KIF23 SNW1 WASHC2C RAPH1 BAZ1A UTP14A NOC3L SMARCA4 PAK2 PTPN23 PHAX TOP1	1.45e-07	934	91	14	33916271
Pubmed	The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.	SMARCA4 CREBBP EP300	1.73e-07	5	91	3	19448667
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRRM1 KIF23 SNW1 BAZ1A CTR9 BRD4 ARID5B SNRNP40 SMARCA4 ZC3H18 ZFC3H1 TOP1 EP300 ZMYM4 KDM1A CBX8	2.31e-07	1294	91	16	30804502
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ACSL1 KIF23 SNW1 NF1 BAZ1A CTR9 UTP14A NOC3L SNRNP40 SMARCA4 PTPN23 CREBBP TOP1 NDUFS1 KDM1A LUZP1	4.19e-07	1353	91	16	29467282
Pubmed	A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes.	SMARCA4 CREBBP EP300	6.02e-07	7	91	3	21079652
Pubmed	Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.	SNW1 CREBBP EP300	6.02e-07	7	91	3	12101239
Pubmed	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	SMARCA4 CREBBP EP300	6.02e-07	7	91	3	9590696
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ATXN2L KIF23 SNW1 BAZ1A UTP14A NOC3L SNRNP40 SMARCA4 ZFC3H1 PHAX TOP1 CBX8	6.99e-07	759	91	12	35915203
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SRRM1 KIF23 SLC4A7 TCF12 AFF2 EPB41L4B SCARF2 UTP14A NOC3L MAGEC3 GAB1 GAB2	8.93e-07	777	91	12	35844135
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ATXN2L SP100 KIF23 SNW1 MRPL15 UTP14A NOC3L SNRNP40 SMARCA4 ZC3H18 ZFC3H1 TOP1 CBX8 LUZP1 METTL14	9.02e-07	1257	91	15	36526897
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	NF1 BRD4 SMARCA4 SMO TOP1	1.25e-06	71	91	5	28319113
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	KIF23 TCF12 BRD4 SMARCA4 TOP1 EP300 ZMYM4 KDM1A DNMT3A	1.37e-06	411	91	9	35182466
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	EHBP1 ATXN2L SRRM1 SLC4A7 WASHC2C SH3KBP1	1.43e-06	133	91	6	15144186
Pubmed	The effects of trichostatin A on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts.	CREBBP EP300 DNMT3A	1.44e-06	9	91	3	18241125
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SNW1 BRD4 UTP14A NOC3L SMARCA4 KDM1A	1.49e-06	134	91	6	25452129
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	EHBP1 BTN3A3 SLC4A7 EPB41L4B COBL MICAL3 PLEKHA6 PLXNB2 GAB1	1.67e-06	421	91	9	36976175
Pubmed	Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes.	SMARCA4 CREBBP EP300 KDM1A	1.92e-06	34	91	4	30894540
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	EHBP1 SLC4A7 NF1 EPB41L4B SCARF2 JPH2 COBL MICAL3 PLEKHA6 GAB1	2.49e-06	569	91	10	30639242
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	TPSAB1 PTPN4 SHANK2 AFF2 SCARF2 BRD4 SH3KBP1 TPSB2	2.53e-06	329	91	8	17474147
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	ARID5B SMARCA4 ZMYM4 KDM1A CBX8 DNMT3A	2.87e-06	150	91	6	28242625
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L WASHC2C CTR9 ARID5B ZC3H18 CREBBP ZMYM4 KDM1A GAB1 LUZP1	3.33e-06	588	91	10	38580884
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	SMARCA4 CREBBP EP300 KDM1A	3.73e-06	40	91	4	34585037
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L SRRM1 NF1 SHANK2 PCLO SH3KBP1 MICAL3 PLEKHA6	3.75e-06	347	91	8	17114649
Pubmed	Interaction network of human early embryonic transcription factors.	TNRC18 BAZ1A ARID5B SMARCA4 CREBBP EP300 ZMYM4 KDM1A	4.08e-06	351	91	8	38297188
Pubmed	Human transcription factor protein interaction networks.	KIF23 SNW1 TCF12 MRPL15 SH3KBP1 UTP14A NOC3L ARID5B SMARCA4 ZC3H18 CREBBP TOP1 EP300 ZMYM4 KDM1A	4.35e-06	1429	91	15	35140242
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SNW1 CTR9 SNRNP40 SMARCA4 ZC3H18 TOP1 DNMT3A	4.53e-06	251	91	7	31076518
Pubmed	Accumulation of NCOA1 dependent on HERC3 deficiency transactivates matrix metallopeptidases and promotes extracellular matrix degradation in intervertebral disc degeneration.	SNW1 BRD4 EP300 GAB1	5.01e-06	43	91	4	36878279
Pubmed	E protein silencing by the leukemogenic AML1-ETO fusion protein.	TCF12 CREBBP EP300	6.18e-06	14	91	3	15333839
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SRRM1 SP100 TCF12 BRD4 CAPRIN2 SMARCA4 ZC3H18 CREBBP IQCM TOP1 EP300 KDM1A LUZP1	6.74e-06	1116	91	13	31753913
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	6.77e-06	2	91	2	27881875
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	6.77e-06	2	91	2	34845315
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	6.77e-06	2	91	2	19729597
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	6.77e-06	2	91	2	10500112
Pubmed	Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.	BRD4 TOP1	6.77e-06	2	91	2	37831776
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	6.77e-06	2	91	2	39287984
Pubmed	KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer.	KDM1A DNMT3A	6.77e-06	2	91	2	38951697
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	6.77e-06	2	91	2	20717166
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	6.77e-06	2	91	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	6.77e-06	2	91	2	11559821
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	6.77e-06	2	91	2	10898108
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	6.77e-06	2	91	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	6.77e-06	2	91	2	19822209
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	6.77e-06	2	91	2	24522976
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	6.77e-06	2	91	2	21847097
Pubmed	MICAL3 Flavoprotein Monooxygenase Forms a Complex with Centralspindlin and Regulates Cytokinesis.	KIF23 MICAL3	6.77e-06	2	91	2	27528609
Pubmed	Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.	GAB1 GAB2	6.77e-06	2	91	2	15952937
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	6.77e-06	2	91	2	34813504
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	6.77e-06	2	91	2	9521329
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	6.77e-06	2	91	2	20301699
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	6.77e-06	2	91	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	6.77e-06	2	91	2	37816914
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	6.77e-06	2	91	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	6.77e-06	2	91	2	10918613
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	6.77e-06	2	91	2	35502657
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	6.77e-06	2	91	2	31898871
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	6.77e-06	2	91	2	30888860
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	6.77e-06	2	91	2	10391906
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	6.77e-06	2	91	2	27881443
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	6.77e-06	2	91	2	19272189
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	6.77e-06	2	91	2	32690000
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	6.77e-06	2	91	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	6.77e-06	2	91	2	21803292
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	6.77e-06	2	91	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	6.77e-06	2	91	2	24089570
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	6.77e-06	2	91	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	6.77e-06	2	91	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	6.77e-06	2	91	2	22303793
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	6.77e-06	2	91	2	34732714
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	6.77e-06	2	91	2	34019788
Pubmed	Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.	GAB1 GAB2	6.77e-06	2	91	2	24998422
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	6.77e-06	2	91	2	15860545
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	6.77e-06	2	91	2	29460469
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	6.77e-06	2	91	2	24551300
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	6.77e-06	2	91	2	8434231
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	6.77e-06	2	91	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	6.77e-06	2	91	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	6.77e-06	2	91	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	6.77e-06	2	91	2	30135524
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	6.77e-06	2	91	2	16596650
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	6.77e-06	2	91	2	29217654
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	6.77e-06	2	91	2	2203827
Interaction	KHDRBS1 interactions	ATXN2L SRRM1 KIF23 SNW1 BRD4 COBLL1 SH3KBP1 SNRNP40 CREBBP TOP1 EP300 KDM1A	8.93e-08	373	89	12	int:KHDRBS1
Interaction	LYN interactions	EHBP1 PRAM1 KIF23 SLC4A7 NF1 EPB41L4B COBLL1 SH3KBP1 PAK2 GAB3 CBLC MICAL3 PLXNB2 CREBBP GAB1 GAB2	9.26e-08	720	89	16	int:LYN
Interaction	CBX3 interactions	SRRM1 SP100 KIF23 SNW1 BRD4 COBLL1 UTP14A SMARCA4 BAHD1 TOP1 EP300 ZMYM4 KDM1A CBX8 METTL14	1.40e-07	646	89	15	int:CBX3
Interaction	RBM25 interactions	ATXN2L SRRM1 SP100 KIF23 BRD4 UTP14A SNRNP40 SMARCA4 ZC3H18 TOP1 EP300	1.82e-07	323	89	11	int:RBM25
Interaction	SRSF1 interactions	SRRM1 KIF23 SNW1 EPB41L4B BRD4 SH3KBP1 UTP14A NOC3L ZC3H18 PHAX TOP1 EP300 METTL14 SMG6	1.94e-07	570	89	14	int:SRSF1
Interaction	PRP4K interactions	ATXN2L SP100 KIF23 SNW1 BAZ1A BRD4 SNRNP40 SMARCA4 ZC3H18 TOP1 EP300	2.18e-07	329	89	11	int:PRP4K
Interaction	CDH1 interactions	EHBP1 ATXN2L SLC4A7 SHANK2 RAPH1 EPB41L4B COBLL1 SH3KBP1 PAK2 INAVA PLEKHA6 CREBBP EP300 GAB1 LUZP1 DNMT3A	2.22e-07	768	89	16	int:CDH1
Interaction	TOP2B interactions	SRRM1 KIF23 CTR9 BRD4 UTP14A SNRNP40 SMARCA4 TOP1 EP300 METTL14	2.76e-07	266	89	10	int:TOP2B
Interaction	SNIP1 interactions	ATXN2L SRRM1 SP100 SNW1 MRPL15 UTP14A NOC3L SNRNP40 SMARCA4 ZC3H18 CREBBP EP300	2.97e-07	417	89	12	int:SNIP1
Interaction	H2BC21 interactions	KIF23 ZNF474 BAZ1A CTR9 BRD4 PCLO SMARCA4 JPH2 ZC3H18 CREBBP TOP1 EP300 ZMYM4 KDM1A CBX8	3.63e-07	696	89	15	int:H2BC21
Interaction	CPSF6 interactions	ATXN2L SRRM1 SNW1 CTR9 BRD4 SNRNP40 ZC3H18 ZFC3H1 METTL16 CREBBP TOP1 EP300 METTL14	5.17e-07	526	89	13	int:CPSF6
Interaction	H2AZ1 interactions	KIF23 BAZ1A BRD4 ARID5B SMARCA4 ZC3H18 BAHD1 TOP1 ZMYM4 METTL14 DNMT3A	7.18e-07	371	89	11	int:H2AZ1
Interaction	CSNK2A1 interactions	SRRM1 PTPN4 KIF23 BAZ1A CTR9 BRD4 SH3KBP1 UTP14A SMARCA4 ZC3H18 ZFC3H1 CREBBP TOP1 EP300 KDM1A CBX8 METTL14	8.16e-07	956	89	17	int:CSNK2A1
Interaction	TERF2IP interactions	SP100 KIF23 SNW1 BRD4 UTP14A SMARCA4 ZC3H18 CREBBP TOP1 ZMYM4 KDM1A CBX8 DNMT3A	8.89e-07	552	89	13	int:TERF2IP
Interaction	CHD3 interactions	SRRM1 KIF23 SNW1 BAZ1A CTR9 BRD4 UTP14A NOC3L SNRNP40 SMARCA4 ZC3H18 CREBBP TOP1 EP300 KDM1A	1.05e-06	757	89	15	int:CHD3
Interaction	SFPQ interactions	SRRM1 SP100 KIF23 SNW1 CTR9 BRD4 SH3KBP1 UTP14A SMARCA4 ZC3H18 TOP1 EP300 METTL14	1.11e-06	563	89	13	int:SFPQ
Interaction	RPL7A interactions	TNRC18 KIF23 EPB41L4B BRD4 UTP14A NOC3L SNRNP40 ZC3H18 PHAX TRDN TOP1 CBX8 GAB2 METTL14	1.57e-06	679	89	14	int:RPL7A
Interaction	EBNA1BP2 interactions	KIF23 SNW1 NF1 BRD4 NOC3L SNRNP40 ZC3H18 TOP1 EP300 METTL14	1.66e-06	324	89	10	int:EBNA1BP2
Interaction	H3C1 interactions	TNRC18 KIF23 SNW1 BAZ1A CTR9 BRD4 COBLL1 NOC3L SMARCA4 CREBBP TOP1 EP300 ZMYM4 KDM1A CBX8 DNMT3A	1.84e-06	901	89	16	int:H3C1
Interaction	ACTC1 interactions	SRRM1 KIF23 SNW1 RAPH1 BRD4 COBLL1 SH3KBP1 SNRNP40 SMARCA4 COBL PHAX ZMYM4 LUZP1 METTL14	2.03e-06	694	89	14	int:ACTC1
Interaction	TOP1 interactions	ATXN2L SRRM1 SP100 KIF23 SNW1 NF1 BAZ1A CTR9 BRD4 SNRNP40 SMARCA4 ZC3H18 TOP1 CBX8	2.10e-06	696	89	14	int:TOP1
Interaction	SRSF6 interactions	SRRM1 KIF23 SNW1 NF1 EPB41L4B BRD4 NOC3L SNRNP40 ZC3H18 ZFC3H1 EP300 METTL14	2.13e-06	503	89	12	int:SRSF6
Interaction	SRSF7 interactions	SRRM1 KIF23 SNW1 MRPL15 BRD4 SH3KBP1 SNRNP40 ZC3H18 PHAX EP300 METTL14	2.69e-06	425	89	11	int:SRSF7
Interaction	SRSF11 interactions	SRRM1 SNW1 BRD4 UTP14A ZC3H18 TOP1 EP300 METTL14	3.24e-06	203	89	8	int:SRSF11
Interaction	CASP8AP2 interactions	SP100 BRD4 SNRNP40 CREBBP KDM1A	3.31e-06	52	89	5	int:CASP8AP2
Interaction	CSNK2B interactions	SRRM1 CTR9 BRD4 SH3KBP1 UTP14A MICAL3 ZC3H18 CREBBP EP300 ZMYM4 KDM1A CBX8 SMG6	3.50e-06	625	89	13	int:CSNK2B
Interaction	DEK interactions	SRRM1 BRD4 UTP14A SMARCA4 ZC3H18 CREBBP EP300 METTL14	4.02e-06	209	89	8	int:DEK
Interaction	HNRNPC interactions	KIF23 SNW1 BRD4 SH3KBP1 UTP14A SNRNP40 SMARCA4 ZC3H18 PHAX TOP1 EP300 KDM1A METTL14	4.09e-06	634	89	13	int:HNRNPC
Interaction	PRPF40A interactions	ATXN2L SRRM1 KIF23 SNW1 BRD4 UTP14A SNRNP40 SMARCA4 ZC3H18 TOP1 EP300	4.27e-06	446	89	11	int:PRPF40A
Interaction	NCOR1 interactions	PRAM1 SNW1 BAZ1A BRD4 SNRNP40 SMARCA4 NR1H3 CREBBP EP300 KDM1A	4.57e-06	363	89	10	int:NCOR1
Interaction	NONO interactions	ATXN2L SRRM1 SP100 KIF23 SNW1 BRD4 SMARCA4 ZC3H18 CREBBP TOP1 EP300 METTL14	5.22e-06	549	89	12	int:NONO
Interaction	YWHAH interactions	EHBP1 ATXN2L SRRM1 PTPN4 KIF23 SLC4A7 NF1 NHSL2 BRD4 COBLL1 PAK2 COBL MTCL1 CREBBP GAB1 LUZP1 GAB2	5.59e-06	1102	89	17	int:YWHAH
Interaction	SNRNP200 interactions	SRRM1 KIF23 SNW1 BRD4 SNRNP40 ZC3H18 PHAX CREBBP TOP1 EP300 METTL14	5.72e-06	460	89	11	int:SNRNP200
Interaction	KCNA3 interactions	EHBP1 ATXN2L SRRM1 AFF2 COBLL1 CAPRIN2 SMARCA4 PAK2 COBL PTPN23 MICAL3 ZC3H18 TOP1 GAB1 LUZP1	5.84e-06	871	89	15	int:KCNA3
Interaction	H1-4 interactions	PRAM1 SP100 TNRC18 KIF23 EPB41L4B CTR9 BRD4 NOC3L SNRNP40 ZC3H18 ZFC3H1 PHAX CBX8	5.92e-06	656	89	13	int:H1-4
Interaction	SRRM2 interactions	SRRM1 PTPN4 KIF23 SNW1 SH3KBP1 UTP14A SNRNP40 SMARCA4 ZC3H18 TOP1 EP300	5.96e-06	462	89	11	int:SRRM2
Interaction	FBXW8 interactions	FER1L4 PCLO ARID5B SNRNP40 ZFC3H1 EP300 LUZP1	6.15e-06	157	89	7	int:FBXW8
Interaction	SCML1 interactions	PTPN4 BRD4 COBLL1 ZC3H18 CBX8	6.22e-06	59	89	5	int:SCML1
Interaction	MYCN interactions	ATXN2L SRRM1 SNW1 TCF12 MRPL15 UTP14A NOC3L SNRNP40 SMARCA4 ZC3H18 PLEKHA6 ZFC3H1 PHAX TOP1 EP300 KDM1A CBX8 DNMT3A SMG6	6.93e-06	1373	89	19	int:MYCN
Interaction	H1-2 interactions	EHBP1 SRRM1 SP100 CTR9 BRD4 NOC3L SNRNP40 XRRA1 ZC3H18 ZFC3H1 PHAX TOP1 METTL14	6.97e-06	666	89	13	int:H1-2
Interaction	DDX5 interactions	ATXN2L SRRM1 KIF23 SNW1 BRD4 SNRNP40 SMARCA4 ZC3H18 CREBBP TOP1 EP300 METTL14	7.36e-06	568	89	12	int:DDX5
Interaction	PNN interactions	SRRM1 KIF23 SNW1 BRD4 SNRNP40 ZC3H18 TRDN TOP1 SMG6	7.53e-06	302	89	9	int:PNN
Interaction	H2BC8 interactions	KIF23 SNW1 BAZ1A BRD4 UTP14A ARID5B SMARCA4 TOP1 ZMYM4 KDM1A CBX8 DNMT3A	8.48e-06	576	89	12	int:H2BC8
Interaction	DDX23 interactions	SRRM1 KIF23 SNW1 CTR9 BRD4 UTP14A NOC3L SNRNP40 ZC3H18 TOP1 EP300	8.55e-06	480	89	11	int:DDX23
Interaction	FXR1 interactions	ATXN2L PRAM1 KIF23 SNW1 BRD4 CAPRIN2 SMARCA4 PAK2 INAVA EP300 CBX8 LUZP1 SMG6	8.57e-06	679	89	13	int:FXR1
Interaction	BUB3 interactions	KIF23 SNW1 BRD4 ZC3H18 ZFC3H1 TOP1 EP300 METTL14	8.66e-06	232	89	8	int:BUB3
Interaction	SNRPA interactions	MYT1L SRRM1 SNW1 MRPL15 CTR9 BRD4 SNRNP40 ZC3H18 ZFC3H1 TOP1 EP300	8.89e-06	482	89	11	int:SNRPA
Interaction	APEX1 interactions	ACSL1 SRRM1 KIF23 SLC4A7 RAPH1 BAZ1A BRD4 UTP14A NOC3L SMARCA4 PLXNB2 NDUFS1 EP300 ZMYM4 KDM1A CBX8 GAB1 METTL14	9.24e-06	1271	89	18	int:APEX1
Interaction	MEN1 interactions	ATXN2L SRRM1 KIF23 SNW1 WASHC2C BAZ1A NOC3L SNRNP40 SMARCA4 COBL ZC3H18 ZFC3H1 TOP1 ZMYM4 CBX8 LUZP1	9.96e-06	1029	89	16	int:MEN1
Interaction	H3C3 interactions	SRRM1 KIF23 BAZ1A BRD4 SMARCA4 ZC3H18 TOP1 ZMYM4 KDM1A CBX8 DNMT3A	1.14e-05	495	89	11	int:H3C3
Interaction	NEUROD1 interactions	TCF12 SMARCA4 CREBBP EP300	1.16e-05	32	89	4	int:NEUROD1
Interaction	PML interactions	ACSL1 SP100 SNW1 TCF12 NF1 WASHC2C BRD4 SNRNP40 SMARCA4 PAK2 CREBBP NDUFS1 EP300 ZMYM4 LUZP1	1.32e-05	933	89	15	int:PML
Interaction	CSNK2A2 interactions	SRRM1 PTPN4 KIF23 CTR9 BRD4 SMARCA4 ZC3H18 ZFC3H1 CREBBP TOP1 EP300 KDM1A CBX8	1.55e-05	718	89	13	int:CSNK2A2
Interaction	HMGA1 interactions	TNRC18 BAZ1A CTR9 BRD4 PCLO SMARCA4 JPH2 ZC3H18 CREBBP ZMYM4	1.60e-05	419	89	10	int:HMGA1
Interaction	RBL1 interactions	SNW1 TCF12 SNRNP40 SMARCA4 TOP1 EP300	1.60e-05	121	89	6	int:RBL1
Interaction	SNRPB interactions	SRRM1 KIF23 SNW1 CTR9 BRD4 SNRNP40 MICAL3 ZC3H18 PHAX TOP1 METTL14	1.71e-05	517	89	11	int:SNRPB
Interaction	DDX17 interactions	ATXN2L KIF23 BRD4 SH3KBP1 SNRNP40 ZC3H18 CREBBP TOP1 EP300 METTL14	1.84e-05	426	89	10	int:DDX17
Interaction	RSF1 interactions	SP100 KIF23 BRD4 SNRNP40 TOP1 EP300	1.84e-05	124	89	6	int:RSF1
Interaction	SRRT interactions	KIF23 BRD4 COBLL1 SNRNP40 ZC3H18 ZFC3H1 PHAX TOP1 EP300	1.93e-05	340	89	9	int:SRRT
Interaction	MTREX interactions	SNW1 BRD4 SNRNP40 ZC3H18 ZFC3H1 TOP1 EP300 METTL14	2.09e-05	262	89	8	int:MTREX
Interaction	PRC1 interactions	ATXN2L SRRM1 KIF23 SNW1 NF1 BRD4 SH3KBP1 NOC3L SNRNP40 COBL ZC3H18 MTCL1 TOP1 NDUFS1 LUZP1	2.17e-05	973	89	15	int:PRC1
Interaction	SIRT7 interactions	ATXN2L SRRM1 KIF23 SNW1 NF1 BRD4 UTP14A NOC3L SMARCA4 ZC3H18 TOP1 NDUFS1 KDM1A	2.25e-05	744	89	13	int:SIRT7
Interaction	SNRNP40 interactions	SRRM1 SNW1 TCF12 BRD4 NOC3L SNRNP40 SMARCA4 ZC3H18 ZFC3H1 PHAX TOP1 CBX8	2.31e-05	637	89	12	int:SNRNP40
Interaction	TXNL4A interactions	SNW1 SNRNP40 ZC3H18 TOP1 EP300	2.31e-05	77	89	5	int:TXNL4A
Interaction	FBL interactions	SP100 KIF23 BRD4 UTP14A NOC3L SNRNP40 ZC3H18 PHAX TOP1 ZMYM4 CBX8 METTL14	2.38e-05	639	89	12	int:FBL
Interaction	POLR1E interactions	BAZ1A CTR9 BRD4 UTP14A NOC3L SNRNP40 ZFC3H1 CREBBP ZMYM4	2.43e-05	350	89	9	int:POLR1E
Interaction	SF3B6 interactions	KIF23 SNW1 UTP14A SNRNP40 ZC3H18 TOP1 EP300	2.43e-05	194	89	7	int:SF3B6
Interaction	TCEA1 interactions	KIF23 CTR9 BRD4 SNRNP40 METTL16 EP300	2.51e-05	131	89	6	int:TCEA1
Interaction	SUPT16H interactions	SRRM1 KIF23 CTR9 BRD4 SNRNP40 SMARCA4 ZC3H18 TOP1 EP300 KDM1A	2.52e-05	442	89	10	int:SUPT16H
Interaction	SMARCC2 interactions	SRRM1 BAZ1A BRD4 SNRNP40 SMARCA4 CREBBP TOP1 EP300 KDM1A	2.60e-05	353	89	9	int:SMARCC2
Interaction	SMARCAD1 interactions	SNW1 BAZ1A BRD4 SNRNP40 SMARCA4 ZC3H18 KDM1A	2.68e-05	197	89	7	int:SMARCAD1
Interaction	ZNF330 interactions	BAZ1A CTR9 UTP14A NOC3L SMARCA4 ZC3H18 ZFC3H1 TOP1 CBX8 DNMT3A	2.72e-05	446	89	10	int:ZNF330
Interaction	CEBPA interactions	ACSL1 ATXN2L PRAM1 TNRC18 SNW1 TCF12 BAZ1A CTR9 BRD4 SNRNP40 SMARCA4 PAK2 CREBBP TOP1 EP300 ZMYM4 KDM1A	2.73e-05	1245	89	17	int:CEBPA
Interaction	RALY interactions	KIF23 SNW1 BRD4 SNRNP40 ZC3H18 ZFC3H1 TOP1 EP300 METTL14	2.78e-05	356	89	9	int:RALY
Interaction	YWHAG interactions	EHBP1 ATXN2L SRRM1 PTPN4 KIF23 SLC4A7 NF1 RAPH1 BAZ1A NHSL2 COBLL1 PAK2 COBL MTCL1 GAB1 LUZP1 GAB2	2.81e-05	1248	89	17	int:YWHAG
Interaction	CTTN interactions	ATXN2L SNW1 SHANK2 NHSL2 BRD4 SMARCA4 CBLC TOP1 EP300 LUZP1	2.94e-05	450	89	10	int:CTTN
Interaction	ISY1 interactions	SRRM1 SNW1 BRD4 SNRNP40 ZC3H18 TOP1	2.98e-05	135	89	6	int:ISY1
Interaction	SMC5 interactions	ATXN2L SRRM1 PRAM1 KIF23 SNW1 BAZ1A BRD4 UTP14A NOC3L SMARCA4 ZC3H18 TOP1 ZMYM4 CBX8 LUZP1	2.98e-05	1000	89	15	int:SMC5
Interaction	SOX7 interactions	TNRC18 ARID5B SMARCA4 CREBBP EP300	3.13e-05	82	89	5	int:SOX7
Interaction	PROX1 interactions	BRD4 CREBBP EP300 KDM1A	3.18e-05	41	89	4	int:PROX1
Interaction	ZNF451 interactions	KIF23 BRD4 SNRNP40 CREBBP KDM1A	3.32e-05	83	89	5	int:ZNF451
Interaction	MACROH2A1 interactions	SP100 KIF23 BRD4 SNRNP40 SMARCA4 ZC3H18 TOP1 CBX8 METTL14 DNMT3A	3.41e-05	458	89	10	int:MACROH2A1
Interaction	CBX4 interactions	ATXN2L BRD4 PCLO CREBBP TOP1 CBX8 DNMT3A	3.46e-05	205	89	7	int:CBX4
Interaction	GNL3 interactions	SP100 KIF23 MRPL15 BRD4 NOC3L SNRNP40 ZC3H18 EP300 METTL14	3.60e-05	368	89	9	int:GNL3
Interaction	UTS2 interactions	KIF23 ZC3H18 EP300	3.65e-05	15	89	3	int:UTS2
Interaction	CRK interactions	PTPN4 BRD4 SH3KBP1 CBLC MAGEC3 C1orf94 KDM1A GAB1 GAB2	3.75e-05	370	89	9	int:CRK
Interaction	ADAR interactions	KIF23 BRD4 PAK2 ZC3H18 ZFC3H1 TOP1 EP300 METTL14	3.90e-05	286	89	8	int:ADAR
Interaction	CDX2 interactions	KIF23 UTP14A SMARCA4 CREBBP EP300	3.94e-05	86	89	5	int:CDX2
Interaction	CBX1 interactions	SP100 BRD4 SMARCA4 BAHD1 EP300 ZMYM4 KDM1A DNMT3A	4.09e-05	288	89	8	int:CBX1
Interaction	SOX2 interactions	ATXN2L TNRC18 KIF23 TCF12 MRPL15 CTR9 UTP14A NOC3L ARID5B SMARCA4 PAK2 JPH2 PHAX TOP1 EP300 KDM1A LUZP1 SMG6	4.16e-05	1422	89	18	int:SOX2
Interaction	NOP56 interactions	KIF23 BRD4 UTP14A NOC3L SNRNP40 SMARCA4 ZC3H18 ZFC3H1 TOP1 EP300 METTL14	4.18e-05	570	89	11	int:NOP56
Interaction	KIF23 interactions	ATXN2L SRRM1 TNRC18 KIF23 BRD4 COBLL1 PCLO SH3KBP1 UTP14A NOC3L MICAL3 ZC3H18 MTCL1 ZFC3H1 TOP1	4.23e-05	1031	89	15	int:KIF23
Interaction	WDR33 interactions	KIF23 SNW1 BRD4 UTP14A ZC3H18 TOP1	4.45e-05	145	89	6	int:WDR33
Interaction	PAF1 interactions	SRRM1 CTR9 BRD4 SNRNP40 TOP1 EP300 DNMT3A	4.55e-05	214	89	7	int:PAF1
Interaction	SSRP1 interactions	SRRM1 KIF23 SNW1 CTR9 BRD4 SNRNP40 SMARCA4 ZC3H18 ZFC3H1 PHAX TOP1 EP300	4.68e-05	685	89	12	int:SSRP1
Interaction	IK interactions	SNW1 BRD4 SNRNP40 ZC3H18 TOP1 EP300 KDM1A	4.69e-05	215	89	7	int:IK
Interaction	PLRG1 interactions	SRRM1 SNW1 BRD4 SNRNP40 ZC3H18 TOP1 EP300	4.83e-05	216	89	7	int:PLRG1
Interaction	DOT1L interactions	ATXN2L SRRM1 KIF23 SNW1 BAZ1A NOC3L SNRNP40 SMARCA4 COBL ZC3H18 ZFC3H1 ZMYM4 LUZP1	5.22e-05	807	89	13	int:DOT1L
Interaction	CLK1 interactions	SRRM1 KIF23 NF1 RAPH1 ZC3H18 MTCL1 C1orf94	5.27e-05	219	89	7	int:CLK1
Interaction	RTF1 interactions	CTR9 BRD4 ZC3H18 EP300 CBX8 DNMT3A	5.38e-05	150	89	6	int:RTF1
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RAPH1 GAB3 PLEKHA6 GAB1 GAB2	4.01e-04	206	55	5	682
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PCLO ZFC3H1	9.30e-04	15	55	2	26
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	1.20e-03	17	55	2	486
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN4 PTPN23	1.35e-03	18	55	2	812
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	1.35e-03	18	55	2	91
GeneFamily	Methyltransferase like	METTL16 METTL14	4.52e-03	33	55	2	963
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EHBP1 PTPN4 SP100 KIF23 SLC4A7 SNW1 TCF12 BAZ1A ARID5B MICAL3 MTCL1 CREBBP TOP1 ZMYM4	1.46e-06	856	91	14	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EHBP1 KIF23 SLC4A7 TCF12 BAZ1A ARID5B MICAL3 MTCL1 CREBBP ZMYM4	5.09e-06	466	91	10	M13522
Coexpression	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	NF1 SH3KBP1 UTP14A SMO MICAL3 ZMYM4	3.28e-05	174	91	6	M6881
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP	TPSAB1 SLC4A7 JPH2 CBLC IQCM TOP1	5.68e-05	192	91	6	M10006
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_UP	ACSL1 EHBP1 KIF23 COBL PLXNB2 GAB2	7.12e-05	200	91	6	M9406
Coexpression	GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN	KIF23 SNW1 TCF12 RAPH1 SH3KBP1 DNMT3A	7.12e-05	200	91	6	M8054
Coexpression	GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN	PTPN4 MAK AFF2 PCLO GAB3 CBLC	7.12e-05	200	91	6	M9028
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP	SRRM1 CAPRIN2 INAVA PPP1R17 METTL16 GAB2	7.12e-05	200	91	6	M9967
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	SRRM1 TNRC18 SLC4A7 NHSL2 ARID5B CREBBP TOP1 DNMT3A	1.22e-05	259	88	8	gudmap_developingGonad_e12.5_epididymis_k3_1000
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRRM1 BAZ1A BRD4 ARID5B TOP1 LUZP1	2.44e-06	188	91	6	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	COVID-19-Mast_cells-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 AFF2 COBL MTCL1 TPSB2	1.72e-05	156	91	5	bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCell	COVID-19-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 AFF2 COBL MTCL1 TPSB2	1.72e-05	156	91	5	159504d43421ee83b9ab484816333ae549c9c2fd
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Undetermined\|Myeloid_cells / Location, Cell class and cell subclass	TPSAB1 AFF2 COBL INAVA TPSB2	2.12e-05	163	91	5	be774c0ba38fa89a9c0076524cf05d593c6c6826
ToppCell	Control-Myeloid-Mast\|Control / Disease state, Lineage and Cell class	TPSAB1 COBLL1 COBL MTCL1 TPSB2	2.60e-05	170	91	5	9a14deb7f7cd4a49c217eba4023f7bf1dec6c902
ToppCell	Control-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	TPSAB1 COBLL1 COBL MTCL1 TPSB2	3.07e-05	176	91	5	0c5916d63e1ada09105e46d2429b75129b7329ec
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 PRAM1 KIF23 AFF2 NHSL2	3.24e-05	178	91	5	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 PRAM1 KIF23 AFF2 NHSL2	3.24e-05	178	91	5	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 PRAM1 KIF23 AFF2 NHSL2	3.50e-05	181	91	5	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 PRAM1 KIF23 AFF2 NHSL2	3.50e-05	181	91	5	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	COPD-Myeloid-Mast\|World / Disease state, Lineage and Cell class	TPSAB1 COBLL1 COBL MTCL1 TPSB2	3.60e-05	182	91	5	68a1e7b804f309bfd6c23d65fad20a9a962712ae
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPN4 SLC4A7 COBLL1 DNMT3A	3.60e-05	182	91	5	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	IPF-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	TPSAB1 AFF2 COBL MTCL1 TPSB2	3.79e-05	184	91	5	7326a16d7d3ae41b8c9d2beaec7f977b374f3469
ToppCell	COPD-Myeloid-Mast\|COPD / Disease state, Lineage and Cell class	TPSAB1 COBLL1 COBL MTCL1 TPSB2	3.99e-05	186	91	5	def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 COBLL1 COBL MTCL1 TPSB2	4.09e-05	187	91	5	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 COBLL1 COBL MTCL1 TPSB2	4.09e-05	187	91	5	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 TPSAB1 SH3KBP1 GAB3 TPSB2	4.31e-05	189	91	5	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	COPD-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	TPSAB1 COBLL1 COBL MTCL1 TPSB2	4.41e-05	190	91	5	379dbac19110b76079a7a53209569e060a852acb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC69 ACSL1 PRAM1 SH3KBP1 GAB2	4.53e-05	191	91	5	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	BAZ1A COBL MTCL1 TOP1 GAB2	4.64e-05	192	91	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL1 PTPN4 SLC4A7 COBLL1 TRDN	4.64e-05	192	91	5	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHANK2 COBLL1 PCLO COBL PLEKHA6	4.76e-05	193	91	5	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	3'_v3-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 COBLL1 COBL MTCL1 TPSB2	4.87e-05	194	91	5	5e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell	3'_v3-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 COBLL1 COBL MTCL1 TPSB2	4.87e-05	194	91	5	7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A7 SHANK2 COBLL1 PCLO COBL	5.12e-05	196	91	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SHANK2 SMARCA4 COBL MTCL1 PLXNB2	5.24e-05	197	91	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TCF12 NF1 SHANK2 GAB1 GAB2	5.37e-05	198	91	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	SP100 SLC4A7 BRD4 COBLL1 ARID5B	5.50e-05	199	91	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	SRRM1 SP100 BRD4 PCLO ARID5B	5.50e-05	199	91	5	c425e7975f492ed5cfcca022248adb627e1d27d4
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	COBLL1 PLA2G3 MTCL1 METTL16 ZMYM4 CBX8 LUZP1 DNMT3A	1.15e-06	197	90	8	6011_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	OLFML2A SLC4A7 ATF7IP2 CBX8 GAB1 BFSP1 SMG6	1.29e-05	196	90	7	4403_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	CCDC69 BRD4 COBLL1 PLEKHA6 SNX19 BAHD1 DNMT3A	1.33e-05	197	90	7	3550_DN
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	OLFML2A ATXN2L SHANK2 BRD4 SMARCA4 PLEKHA6 CBX8	1.37e-05	198	90	7	6790_DN
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A	CCDC69 OLFML2A ATXN2L BTN3A3 PLA2G3 PLEKHA6 CBX8	1.37e-05	198	90	7	4378_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	EHBP1 ATXN2L NF1 AFF2 COBLL1 UTP14A METTL16	1.37e-05	198	90	7	4729_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	ATXN2L SLC4A7 BRD4 PLA2G3 CAPRIN2 MTCL1 BFSP1	1.47e-05	200	90	7	3465_DN
Drug	(E)-4-aminohex-4-enoic acid	TPSAB1 TOP1 TPSB2	3.22e-05	16	90	3	CID005288385
Drug	thymidine glycol monophosphate	TPSAB1 TPSB2	4.62e-05	3	90	2	CID000165415
Drug	atracurium besylate	TPSAB1 BRD4 TPSB2	8.71e-05	22	90	3	CID000047320
Drug	Brunfelsamidine	TPSAB1 TPSB2	9.22e-05	4	90	2	CID005281683
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	SP100 KIF23 NF1 COBLL1 EP300 BFSP1	1.06e-04	189	90	6	5084_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	EHBP1 COBLL1 PLA2G3 UTP14A DNMT3A SMG6	1.15e-04	192	90	6	6435_DN
Drug	5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA	OLFML2A ATXN2L NF1 SHANK2 PLA2G3 MTCL1	1.15e-04	192	90	6	960_UP
Drug	yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA	EHBP1 SLC4A7 NF1 NR1H3 LUZP1 DNMT3A	1.22e-04	194	90	6	1119_UP
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ATXN2L PLA2G3 METTL16 SNX19 CBX8 DNMT3A	1.22e-04	194	90	6	2787_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	CCDC69 ATXN2L SHANK2 UTP14A MICAL3 PLEKHA6	1.22e-04	194	90	6	6779_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	ATXN2L SLC4A7 NF1 AFF2 COBL GAB1	1.22e-04	194	90	6	4546_UP
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SP100 NF1 METTL16 CBX8 GAB1 LUZP1	1.25e-04	195	90	6	3320_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	ATXN2L SP100 AFF2 CBX8 DNMT3A SMG6	1.25e-04	195	90	6	4742_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	OLFML2A NF1 COBLL1 MICAL3 CBX8 GAB1	1.25e-04	195	90	6	3530_DN
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CRYBG2 NF1 AFF2 PLA2G3 METTL16 SMG6	1.25e-04	195	90	6	3212_UP
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	EHBP1 OLFML2A NF1 BRD4 CAPRIN2 NR1H3	1.29e-04	196	90	6	1474_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A	CRYBG2 MAK NF1 UTP14A METTL16 CBX8	1.29e-04	196	90	6	3726_DN
Drug	Vidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A	PCLO UTP14A TNNT3 CREBBP GAB1 BFSP1	1.29e-04	196	90	6	2706_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CCDC69 ATXN2L NF1 AFF2 ATF7IP2 DNMT3A	1.32e-04	197	90	6	4764_DN
Drug	ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A	ATXN2L CRYBG2 SHANK2 NR1H3 GAB1 DNMT3A	1.32e-04	197	90	6	2665_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	SLC4A7 COBLL1 PLEKHA6 CBX8 BFSP1 SMG6	1.32e-04	197	90	6	4717_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CCDC69 ATXN2L NF1 AFF2 UTP14A DNMT3A	1.32e-04	197	90	6	4730_DN
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A	SLC4A7 TCF12 NF1 MICAL3 MTCL1 CBX8	1.32e-04	197	90	6	7064_DN
Drug	Ofloxacin [82419-36-1]; Down 200; 11uM; MCF7; HT_HG-U133A	OLFML2A ATXN2L SLC4A7 NF1 SHANK2 LUZP1	1.32e-04	197	90	6	2302_DN
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; PC3; HT_HG-U133A	OLFML2A BRD4 COBLL1 BAHD1 BFSP1 SMG6	1.32e-04	197	90	6	6633_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A	ATXN2L SP100 BRD4 COBLL1 CAPRIN2 SNX19	1.32e-04	197	90	6	3444_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ATXN2L SP100 SLC4A7 AFF2 PCLO DNMT3A	1.36e-04	198	90	6	4750_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	OLFML2A PLA2G3 CAPRIN2 METTL16 LUZP1 BFSP1	1.36e-04	198	90	6	1648_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CCDC69 SP100 NF1 CAPRIN2 PLEKHA6 GAB2	1.36e-04	198	90	6	1491_DN
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A	CCDC69 EHBP1 SLC4A7 COBLL1 ATF7IP2 BFSP1	1.36e-04	198	90	6	3440_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	EHBP1 OLFML2A BTN3A3 COBLL1 COBL PLEKHA6	1.36e-04	198	90	6	2088_DN
Drug	Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ATXN2L SHANK2 COBLL1 CAPRIN2 COBL CBX8	1.36e-04	198	90	6	6827_DN
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	GDF5 MAK SHANK2 UTP14A PLEKHA6 DNMT3A	1.40e-04	199	90	6	6828_UP
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	CBLC COBL SMO PLEKHA6 GAB1 DNMT3A	1.40e-04	199	90	6	3784_UP
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	NF1 BRD4 UTP14A PLEKHA6 BFSP1 DNMT3A	1.40e-04	199	90	6	3341_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ATXN2L SP100 SLC4A7 NF1 BRD4 ATF7IP2	1.40e-04	199	90	6	7029_UP
Drug	arachidonic acid sodium salt; Down 200; 10uM; MCF7; HG-U133A	ATXN2L COBL SMO TNNT3 LUZP1 GAB2	1.44e-04	200	90	6	604_DN
Drug	CAS 83919-23-7	TPSAB1 CREBBP TPSB2	1.45e-04	26	90	3	CID000004240
Drug	3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide	CREBBP EP300	1.53e-04	5	90	2	ctd:C575894
Disease	vital capacity	CCDC69 EHBP1 GDF5 ATXN2L ZNF474 EPB41L4B BRD4 PCLO CAPRIN2 ARID5B JPH2 GAB3 MICAL3 MTCL1 GAB1 SMG6	1.10e-06	1236	91	16	EFO_0004312
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	9.41e-06	2	91	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	9.41e-06	2	91	2	cv:C4551859
Disease	Menke-Hennekam syndrome	CREBBP EP300	9.41e-06	2	91	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	9.41e-06	2	91	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	9.41e-06	2	91	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	9.41e-06	2	91	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	9.41e-06	2	91	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	9.41e-06	2	91	2	C0035934
Disease	platelet crit	SRRM1 SLC4A7 NF1 NHSL2 NOC3L ARID5B PAK2 JPH2 ZC3H18 PLEKHA6 CBX8 SMG6	3.60e-05	952	91	12	EFO_0007985
Disease	lymphocyte count	CCDC69 PTPN4 SLC4A7 RAPH1 COBLL1 NOC3L ARID5B PAK2 JPH2 MICAL3 PLEKHA6 PLXNB2 GAB2 DNMT3A SMG6	3.96e-05	1464	91	15	EFO_0004587
Disease	Sezary Syndrome	SMARCA4 CREBBP DNMT3A	7.87e-05	27	91	3	C0036920
Disease	platelet-activating factor measurement	BTN3A3 IQCM	9.35e-05	5	91	2	EFO_0801075
Disease	intraocular pressure measurement	TCF12 ZNF474 PCLO ARID5B NR1H3 TRDN GAB2 SMG6	1.80e-04	509	91	8	EFO_0004695
Disease	Leukemia, Myelocytic, Acute	NF1 CBLC CREBBP EP300 DNMT3A	2.02e-04	173	91	5	C0023467
Disease	apolipoprotein B measurement	EHBP1 TCF12 NF1 RAPH1 FER1L4 COBLL1 SMARCA4 CBLC TOP1	2.10e-04	663	91	9	EFO_0004615
Disease	renin measurement	PLEKHA6 TNNT3	2.60e-04	8	91	2	EFO_0010616
Disease	tryptase beta-2 measurement	TPSAB1 TPSB2	3.34e-04	9	91	2	EFO_0008306
Disease	remnant cholesterol measurement	EHBP1 SMARCA4 CBLC TOP1	3.55e-04	108	91	4	EFO_0010815
Disease	alcohol consumption measurement	MYT1L EHBP1 ATXN2L NF1 RAPH1 COBLL1 PCLO ARID5B COBL MICAL3 EP300 CBX8	4.30e-04	1242	91	12	EFO_0007878
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	COBLL1 SMARCA4 CBLC GAB2	5.46e-04	121	91	4	EFO_0008595, EFO_0020943
Disease	eye morphology measurement	MYT1L WASHC2C CAPRIN2 KDM1A LUZP1	5.84e-04	218	91	5	EFO_0007858
Disease	Small cell carcinoma of lung	SMARCA4 CREBBP EP300	6.28e-04	54	91	3	C0149925
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	COBLL1 SMARCA4 CBLC TOP1	6.36e-04	126	91	4	EFO_0004611, EFO_0010351
Disease	hip circumference	GDF5 ATXN2L NF1 SHANK2 COBLL1 ARID5B	6.36e-04	338	91	6	EFO_0005093
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	EHBP1 COBLL1 SMARCA4 CBLC TOP1	6.60e-04	224	91	5	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	EHBP1 COBLL1 SMARCA4 CBLC TOP1	6.73e-04	225	91	5	EFO_0008317, EFO_0010351
Disease	Sarcoma, Spindle Cell	NF1 SMARCA4	8.36e-04	14	91	2	C0205945
Disease	Sarcoma, Epithelioid	NF1 SMARCA4	8.36e-04	14	91	2	C0205944
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ARID5B CREBBP EP300	8.97e-04	61	91	3	C1961102
Disease	triglycerides to total lipids in medium VLDL percentage	PRAM1 COBLL1 SMARCA4	9.86e-04	63	91	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	PRAM1 COBLL1 SMARCA4	9.86e-04	63	91	3	EFO_0022239
Disease	T-Cell Lymphoma	EP300 KDM1A	1.10e-03	16	91	2	C0079772
Disease	triglycerides to total lipids in very small VLDL percentage	PRAM1 COBLL1 SMARCA4	1.28e-03	69	91	3	EFO_0022341
Disease	chronic obstructive pulmonary disease	CCDC69 EHBP1 SCARF2 MICAL3 MTCL1 GAB2 DNMT3A SMG6	1.30e-03	688	91	8	EFO_0000341
Disease	Juvenile Myelomonocytic Leukemia	NF1 DNMT3A	1.55e-03	19	91	2	C0349639
Disease	red blood cell density measurement	SRRM1 WASHC2C BAZ1A BRD4 COBLL1 METTL16 TOP1 DNMT3A SMG6	1.58e-03	880	91	9	EFO_0007978
Disease	free cholesterol to total lipids in small VLDL percentage	PRAM1 COBLL1 SMARCA4	1.63e-03	75	91	3	EFO_0022287
Disease	base metabolic rate measurement	GDF5 MICAL3	1.72e-03	20	91	2	EFO_0007777
Disease	urticaria	TPSAB1 TPSB2	1.72e-03	20	91	2	EFO_0005531
Disease	Osteoarthritis of hip	GDF5 SMO	1.72e-03	20	91	2	C0029410
Disease	seborrheic dermatitis	TNRC18 C1orf94	1.72e-03	20	91	2	EFO_1000764
Disease	Sarcoma	NF1 SMARCA4	1.90e-03	21	91	2	C1261473
Disease	sexual dimorphism measurement	GDF5 ATXN2L PRAM1 NF1 FER1L4 COBLL1 SMARCA4 CBLC PTPN23 DNMT3A	2.16e-03	1106	91	10	EFO_0021796
Disease	acute myeloid leukemia (is_implicated_in)	NF1 CREBBP DNMT3A	2.26e-03	84	91	3	DOID:9119 (is_implicated_in)
Disease	smoking status measurement, chronic obstructive pulmonary disease	CCDC69 MICAL3 MTCL1	2.58e-03	88	91	3	EFO_0000341, EFO_0006527
Disease	Intellectual Disability	MYT1L NF1 SHANK2 BRD4 PTPN23 DNMT3A	2.64e-03	447	91	6	C3714756
Disease	level of Sterol ester (27:1/18:2) in blood serum	SMARCA4 CBLC	2.91e-03	26	91	2	OBA_2045194
Disease	level of Sterol ester (27:1/16:0) in blood serum	SMARCA4 CBLC	2.91e-03	26	91	2	OBA_2045191
Disease	forced expiratory volume	GDF5 ATXN2L SCARF2 MICAL3 MTCL1 PLXNB2 CBX8 GAB1	3.05e-03	789	91	8	EFO_0004314

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSRLRNKPKIKEPPG	SMG6	56	Q86US8
HPPDQKIPKPKRLQE	EP300	1451	Q09472
RKQTVKEPPPVQKPE	ANTXRL	376	A6NF34
TEPRTNLKLPEPPRK	BTN3A3	446	O00478
DLPPRKPRNAQPKVR	CBLC	441	Q9ULV8
KVYPPVPAEKRKPIR	DNMT3A	621	Q9Y6K1
RPVKPPKKDVPDSQQ	BRD4	326	O60885
RANRRKPKPPAPEDL	ACSL1	256	P33121
RKEPRPNIPLAPEKK	AFF2	681	P51816
CHPPDQKIPKPKRLQ	CREBBP	1486	Q92793
PDKLPELPAQKRQLP	C1orf94	301	Q6P1W5
PRPQDAPARRKPKAK	COBLL1	6	Q53SF7
PFPPRILKEEPKGKE	ATXN2L	566	Q8WWM7
RKPFVRQKPPADLRP	BAZ1A	6	Q9NRL2
CKPPKKKRQEPEPEQ	CCDC69	11	A6NI79
VKKAPPPTRPKRNDS	RAPH1	1116	Q70E73
KERQPIKPEPKSQPR	IQCM	236	A0A1B0GVH7
SPKLQRKPLPKADQP	MTCL1	1711	Q9Y4B5
QLLDRELKKKPPPRP	PTPN23	706	Q9H3S7
DPNKPIRKQLKRGSP	PTPN4	86	P29074
PTEIRPQKRKKGPAP	NR1H3	76	Q13133
RETPAKLEPKPIIPK	JPH2	616	Q9BR39
KLEPKPIIPKAEPRA	JPH2	621	Q9BR39
RLFPEPLLPKEKPKA	MICAL3	1196	Q7RTP6
LKKAREPGPPREPKE	GDF5	146	P43026
LPPQPQPRKKATDKD	MAGEC3	36	Q8TD91
PPPVDRNLKPDRKVK	GAB1	516	Q13480
RNLKPDRKVKPAPLE	GAB1	521	Q13480
DRKVKPAPLEIKPLP	GAB1	526	Q13480
PPVNRDLKPQRKSRP	GAB3	436	Q8WWW8
DLKPQRKSRPPPLDL	GAB3	441	Q8WWW8
EIERLRPKSPPPKSK	METTL14	391	Q9HCE5
KGRKQPEPLEKPSRP	FER1L4	1721	A9Z1Z3
AQKKVKRTLPNPPPE	PCLO	3716	Q9Y6V0
PPEVQPPPKRRQKRD	PLXNB2	1151	O15031
DPLQAKKVRKVPPGL	TCF12	176	Q99081
PSPPSKRRKLEKPRK	METTL16	296	Q86W50
SLKPLPSVPEEKKPR	PAK2	36	Q13177
RNAKAEKEKKLPPPP	KDM1A	141	O60341
SKKRGPKPRKELPDP	CBX8	196	Q9HC52
PRQKALPKNVPRRKE	BFSP1	361	Q12934
PAQEIINRLKKPPPV	GUCY2F	756	P51841
YIPPPKEKRPEGRLK	CRYBG2	101	Q8N1P7
IDLQKKKRRAPAPPP	COBL	326	O75128
ENGPKPKKRRPPKAE	CTR9	976	Q6PD62
PLRKRPLVPEKPKAC	BAHD1	56	Q8TBE0
APLPPRKEQEIKESP	CAPRIN2	771	Q6IMN6
RVKRKAPAPPVLSPK	EHBP1	396	Q8NDI1
RDTLPPQKPELKVKR	ATF7IP2	571	Q5U623
KRKKDSPFRLPEPVP	MAK	431	P20794
EPEPKPQPNSREKAK	LUZP1	681	Q86V48
PAVEKPEIKPPRVRK	EPB41L4B	661	Q9H329
PLKPGEKAPKVRRRI	INAVA	156	Q3KP66
DKKKRPPQRPEGLLS	PRR18	31	Q8N4B5
RGLPKPPKEKLLQVE	OLFML2A	246	Q68BL7
KRKRQKCFNPPPKPE	PHAX	81	Q9H814
PIKPKPPQSKLLRED	KIF23	241	Q02241
PIPLENPKEKRPGKR	NOC3L	61	Q8WTT2
PPVNRNLKPDRKAKP	GAB2	511	Q9UQC2
DERLPPPFPLKQVKV	TPSAB1	166	Q15661
DERLPPPFPLKQVKV	TPSB2	166	P20231
EPPKSVPSQEKRKIP	SLC4A7	536	Q9Y6M7
NLKPNPGSKKPERRP	MRPL15	26	Q9P015
DPLRPPSQIPKRKRK	TMEM200C	16	A6NKL6
KTKPPVAEKPPVARR	NHSL2	866	Q5HYW2
KPGVEAIRKNPPKVL	NDUFS1	531	P28331
RRPPQDPALRKEKDP	PRAM1	536	Q96QH2
LPPDFEKEGNRPKKP	SH3KBP1	326	Q96B97
KRKGPELPLVPVKRQ	SNRNP40	6	Q96DI7
KKRGRPPAEKLSPNP	SMARCA4	1441	P51532
SPAPPKPRQKQHLRK	PLA2G3	296	Q9NZ20
DDTARKKAPPPPKRA	SHANK2	726	Q9UPX8
GEEDKPLPPIKPRKQ	ARID5B	411	Q14865
KKPRRKDTPALHIPP	PPP1R17	61	O96001
PPEPVDKRAKAPKAR	TNRC18	2376	O15417
DKRAKAPKARPAPPQ	TNRC18	2381	O15417
RRPERPEVKKEPPVK	PLEKHA6	221	Q9Y2H5
EKRESPSPAPKPRKV	SRRM1	446	Q8IYB3
QGPREKPAPPQKAKR	SCARF2	796	Q96GP6
KKFKDPNAPKRPPLA	SP100	761	P23497
ILDKKPPPRIERGLK	NF1	1426	P21359
SLKEPQKPEQPTPRK	WASHC2C	426	Q9Y4E1
IKAPEGPPRKDKNLP	UTP14A	651	Q9BVJ6
PMEPPRFKINKKIPR	SNW1	206	Q13573
KAPEKDPEQPPKGRV	SNX19	781	Q92543
RKRKKEVCPLAPPPE	SMO	676	Q99835
PKPTKKAEHREREPP	TRDN	576	Q13061
LKNLPTPPPKLKRAR	ZSWIM3	431	Q96MP5
EEEKPRPKLTAPKIP	TNNT3	46	P45378
KLPKHLRRPEPSKPQ	ZNF474	126	Q6S9Z5
FVPPKEDIKPLKRPR	TOP1	126	P11387
PKVPPKSEKENDPLR	ZFC3H1	751	O60293
EKRAQRIPIPPPKKT	XRRA1	671	Q6P2D8
KLPPSQPPRLLKNKA	ZMYM4	931	Q5VZL5
REKEKGKPKPRSPQP	ZC3H18	476	Q86VM9
KQPQEPAPKRKPFAV	MYT1L	66	Q9UL68